Loading...

Daniel Werb

TitleAssistant Adjunct Professor
InstitutionUniversity of California San Diego
DepartmentMedicine
Address9500 Gilman Drive #0507
La Jolla CA 92093
vCardDownload vCard

    Collapse Research 
    Collapse Research Activities and Funding
    Preventing HIV by modifying the context for injecting initiation
    NIH/NIDA DP2DA040256Jul 1, 2015 - Jun 30, 2020
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Meyers SA, Scheim A, Jain S, Sun X, Milloy MJ, DeBeck K, Hayashi K, Garfein RS, Werb D. Gender differences in the provision of injection initiation assistance: a comparison of three North American settings. Harm Reduct J. 2018 Dec 04; 15(1):59. PMID: 30514384.
      View in: PubMed
    2. Goodman-Meza D, Medina-Mora ME, Magis-Rodríguez C, Landovitz RJ, Shoptaw S, Werb D. Where Is the Opioid Use Epidemic in Mexico? A Cautionary Tale for Policymakers South of the US-Mexico Border. Am J Public Health. 2018 Nov 29; e1-e10. PMID: 30495992.
      View in: PubMed
    3. Rafful C, Jain S, Sun X, Strathdee SA, Garfein RS, Cuevas-Mota J, Magis-Rodríguez C, Smith LR, Werb D. Identification of a Syndemic of Blood-Borne Disease Transmission and Injection drug Use Initiation at the US-Mexico Border. J Acquir Immune Defic Syndr. 2018 Sep 14. PMID: 30222661.
      View in: PubMed
    4. Beletsky L, Baker P, Arredondo J, Emuka A, Goodman-Meza D, Medina-Mora ME, Werb D, Davidson P, Amon JJ, Strathdee S, Magis-Rodriguez C. The global health and equity imperative for safe consumption facilities. Lancet. 2018 Aug 18; 392(10147):553-554. PMID: 30152386.
      View in: PubMed
    5. Scheim A, Werb D. Integrating supervised consumption into a continuum of care for people who use drugs. CMAJ. 2018 Aug 07; 190(31):E921-E922. PMID: 30087127.
      View in: PubMed
    6. Ospina-Escobar A, Magis-Rodríguez C, Juárez F, Werb D, Bautista Arredondo S, Carreón R, Ramos ME, Strathdee S. Comparing risk environments for HIV among people who inject drugs from three cities in Northern Mexico. Harm Reduct J. 2018 May 18; 15(1):27. PMID: 29776368.
      View in: PubMed
    7. Guise A, Melo J, Mittal ML, Rafful C, Cuevas-Mota J, Davidson P, Garfein RS, Werb D. A fragmented code: The moral and structural context for providing assistance with injection drug use initiation in San Diego, USA. Int J Drug Policy. 2018 Mar 07; 55:51-60. PMID: 29524733.
      View in: PubMed
    8. Rafful C, Orozco R, Rangel G, Davidson P, Werb D, Beletsky L, Strathdee SA. Increased non-fatal overdose risk associated with involuntary drug treatment in a longitudinal study with people who inject drugs. Addiction. 2018 Jun; 113(6):1056-1063. PMID: 29333664.
      View in: PubMed
    9. Werb D, Bluthenthal RN, Kolla G, Strike C, Kral AH, Uusküla A, Des Jarlais D. Preventing Injection Drug use Initiation: State of the Evidence and Opportunities for the Future. J Urban Health. 2018 Feb; 95(1):91-98. PMID: 28948444.
      View in: PubMed
    10. Ben Hamida A, Rafful C, Jain S, Sun S, Gonzalez-Zuniga P, Rangel G, Strathdee SA, Werb D. Non-injection Drug Use and Injection Initiation Assistance among People Who Inject Drugs in Tijuana, Mexico. J Urban Health. 2018 Feb; 95(1):83-90. PMID: 28815465.
      View in: PubMed
    11. Melo JS, Mittal ML, Horyniak D, Strathdee SA, Werb D. Injection Drug Use Trajectories Among Migrant Populations: A Narrative Review. Subst Use Misuse. 2018 Jan 24; 1-13. PMID: 29364762.
      View in: PubMed
    12. Rafful C, Melo J, Medina-Mora ME, Rangel G, Sun X, Jain S, Werb D. Cross-border migration and initiation of others into drug injecting in Tijuana, Mexico. Drug Alcohol Rev. 2018 Apr; 37 Suppl 1:S277-S284. PMID: 29168262.
      View in: PubMed
    13. Mittal ML, Vashishtha D, Sun S, Jain S, Cuevas-Mota J, Garfein R, Strathdee SA, Werb D. History of medication-assisted treatment and its association with initiating others into injection drug use in San Diego, CA. Subst Abuse Treat Prev Policy. 2017 Oct 03; 12(1):42. PMID: 28974239.
      View in: PubMed
    14. Guise A, Horyniak D, Melo J, McNeil R, Werb D. The experience of initiating injection drug use and its social context: a qualitative systematic review and thematic synthesis. Addiction. 2017 Dec; 112(12):2098-2111. PMID: 28734128.
      View in: PubMed
    15. Werb D. Post-war prevention: Emerging frameworks to prevent drug use after the War on Drugs. Int J Drug Policy. 2018 Jan; 51:160-164. PMID: 28734744.
      View in: PubMed
    16. Vashishtha D, Mittal ML, Werb D. The North American opioid epidemic: current challenges and a call for treatment as prevention. Harm Reduct J. 2017 May 12; 14(1):7. PMID: 28494762.
      View in: PubMed
    17. To MJ, Palepu A, Matheson FI, Ecker J, Farrell S, Hwang SW, Werb D. The effect of incarceration on housing stability among homeless and vulnerably housed individuals in three Canadian cities: A prospective cohort study. Can J Public Health. 2017 Mar 01; 107(6):e550-e555. PMID: 28252374.
      View in: PubMed
    18. Wood EF, Werb D, Beletsky L, Rangel G, Cuevas Mota J, Garfein RS, Strathdee SA, Wagner KD. Differential experiences of Mexican policing by people who inject drugs residing in Tijuana and San Diego. Int J Drug Policy. 2017 03; 41:132-139. PMID: 28111221.
      View in: PubMed
    19. Klimas J, Wood E, Werb D. How can we investigate the role of topiramate in the treatment of cocaine use disorder more thoroughly? Addiction. 2017 Jan; 112(1):182-183. PMID: 27813211.
      View in: PubMed
    20. Gaines TL, Werb D, Arredondo J, Alaniz VM, Vilalta C, Beletsky L. The Spatial-Temporal Pattern of Policing Following a Drug Policy Reform: Triangulating Self-Reported Arrests With Official Crime Statistics. Subst Use Misuse. 2017 Jan 28; 52(2):214-222. PMID: 27767367.
      View in: PubMed
    21. Werb D, Garfein R, Kerr T, Davidson P, Roux P, Jauffret-Roustide M, Auriacombe M, Small W, Strathdee SA. A socio-structural approach to preventing injection drug use initiation: rationale for the PRIMER study. Harm Reduct J. 2016 09 15; 13(1):25. PMID: 27629248.
      View in: PubMed
    22. Beletsky L, Arredondo J, Werb D, Vera A, Abramovitz D, Amon JJ, Brouwer KC, Strathdee SA, Gaines TL. Utilization of Google enterprise tools to georeference survey data among hard-to-reach groups: strategic application in international settings. Int J Health Geogr. 2016 07 28; 15(1):24. PMID: 27468764; PMCID: PMC4964042.
    23. Werb D, Strathdee SA, Vera A, Arredondo J, Beletsky L, Gonzalez-Zuniga P, Gaines T. Spatial patterns of arrests, police assault and addiction treatment center locations in Tijuana, Mexico. Addiction. 2016 Jul; 111(7):1246-56. PMID: 26879179; PMCID: PMC4899159 [Available on 07/01/17].
    24. Werb D, Kazatchkine M, Kerr T, Nutt D, Strathdee S, Hankins C, Hayashi K, Montaner J, Jarlais DD, Maghsoudi N, Wood E. A call to reprioritise metrics to evaluate illicit drug policy. Lancet. 2016 Apr 02; 387(10026):1371. PMID: 27115811.
      View in: PubMed
    25. Singh M, Keer D, Klimas J, Wood E, Werb D. Topiramate for cocaine dependence: a systematic review and meta-analysis of randomized controlled trials. Addiction. 2016 Aug; 111(8):1337-46. PMID: 26826006.
      View in: PubMed
    26. Harvey-Vera AY, González-Zúñiga P, Vargas-Ojeda AC, Medina-Mora ME, Magis-Rodríguez CL, Wagner K, Strathdee SA, Werb D. Risk of violence in drug rehabilitation centers: perceptions of people who inject drugs in Tijuana, Mexico. Subst Abuse Treat Prev Policy. 2016 Jan 26; 11:5. PMID: 26812913; PMCID: PMC4728769.
    27. Smith DM, Werb D, Abramovitz D, Magis-Rodriguez C, Vera A, Patterson TL, Strathdee SA. Predictors of needle exchange program utilization during its implementation and expansion in Tijuana, Mexico. Am J Addict. 2016 Mar; 25(2):118-24. PMID: 26765073.
      View in: PubMed
    28. Werb D, Kamarulzaman A, Meacham MC, Rafful C, Fischer B, Strathdee SA, Wood E. The effectiveness of compulsory drug treatment: A systematic review. Int J Drug Policy. 2016 Feb; 28:1-9. PMID: 26790691; PMCID: PMC4752879 [Available on 02/01/17].
    29. Werb D, Strathdee SA, Meza E, Rangel Gomez MG, Palinkas L, Medina-Mora ME, Beletsky L. Institutional stakeholder perceptions of barriers to addiction treatment under Mexico's drug policy reform. Glob Public Health. 2017 05; 12(5):519-530. PMID: 28278755.
      View in: PubMed
    30. Rafful C, Wagner KD, Werb D, González-Zúñiga PE, Verdugo S, Rangel G, Strathdee SA. Prevalence and correlates of neck injection among people who inject drugs in Tijuana, Mexico. Drug Alcohol Rev. 2015 Nov; 34(6):630-6. PMID: 25867795; PMCID: PMC4869533.
    31. Gaines TL, Beletsky L, Arredondo J, Werb D, Rangel G, Vera A, Brouwer K. Examining the spatial distribution of law enforcement encounters among people who inject drugs after implementation of Mexico's drug policy reform. J Urban Health. 2015 Apr; 92(2):338-51. PMID: 25300503; PMCID: PMC4411320.
    32. Rafful C, Zule W, González-Zúñiga PE, Werb D, Medina-Mora ME, Magis-Rodriguez C, Strathdee SA. High dead-space syringe use among people who inject drugs in Tijuana, Mexico. Am J Drug Alcohol Abuse. 2015 May; 41(3):220-5. PMID: 25695145; PMCID: PMC4603554.
    33. Werb D, Richardson C, Buxton J, Shoveller J, Wood E, Kerr T. Development of a brief substance use sensation seeking scale: validation and prediction of injection-related behaviors. AIDS Behav. 2015 Feb; 19(2):352-61. PMID: 25119056; PMCID: PMC4450886.
    34. Mackey TK, Werb D, Beletsky L, Rangel G, Arredondo J, Strathdee SA. Mexico's "ley de narcomenudeo" drug policy reform and the international drug control regime. Harm Reduct J. 2014 Nov 14; 11(1):31. PMID: 25395346; PMCID: PMC4234880.
    35. Werb D, Mora ME, Beletsky L, Rafful C, Mackey T, Arredondo J, Strathdee SA. Mexico's drug policy reform: cutting edge success or crisis in the making? Int J Drug Policy. 2014 Sep; 25(5):823-5. PMID: 24974368; PMCID: PMC4169748.
    36. Werb D, Kerr T, Buxton J, Shoveller J, Richardson C, Montaner J, Wood E. Crystal methamphetamine and initiation of injection drug use among street-involved youth in a Canadian setting. CMAJ. 2013 Dec 10; 185(18):1569-75. PMID: 24130244; PMCID: PMC3855114.
    37. Werb D, Kerr T, Nosyk B, Strathdee S, Montaner J, Wood E. The temporal relationship between drug supply indicators: an audit of international government surveillance systems. BMJ Open. 2013 Sep 30; 3(9):e003077. PMID: 24080093; PMCID: PMC3787412.
    38. Werb D, Buxton J, Shoveller J, Richardson C, Rowell G, Wood E. Interventions to prevent the initiation of injection drug use: a systematic review. Drug Alcohol Depend. 2013 Dec 01; 133(2):669-76. PMID: 24055187.
      View in: PubMed
    39. Werb D, Kerr T, Buxton J, Shoveller J, Richardson C, Montaner J, Wood E. Patterns of injection drug use cessation during an expansion of syringe exchange services in a Canadian setting. Drug Alcohol Depend. 2013 Oct 01; 132(3):535-40. PMID: 23642315; PMCID: PMC3762907.
    40. Chami G, Werb D, Feng C, DeBeck K, Kerr T, Wood E. Neighborhood of residence and risk of initiation into injection drug use among street-involved youth in a Canadian setting. Drug Alcohol Depend. 2013 Oct 01; 132(3):486-90. PMID: 23587537; PMCID: PMC3927649.
    41. Werb D, Milloy MJ, Kerr T, Zhang R, Montaner J, Wood E. Injection drug use and HIV antiretroviral therapy discontinuation in a Canadian setting. AIDS Behav. 2013 Jan; 17(1):68-73. PMID: 22249956; PMCID: PMC4931799.
    42. Werb D, Nosyk B, Kerr T, Fischer B, Montaner J, Wood E. Estimating the economic value of British Columbia's domestic cannabis market: implications for provincial cannabis policy. Int J Drug Policy. 2012 Nov; 23(6):436-41. PMID: 23085258.
      View in: PubMed
    43. Hadland SE, Werb D, Kerr T, Fu E, Wang H, Montaner JS, Wood E. Childhood sexual abuse and risk for initiating injection drug use: a prospective cohort study. Prev Med. 2012 Nov; 55(5):500-4. PMID: 22954518; PMCID: PMC3489963.
    44. Werb D, Bouchard M, Kerr T, Shoveller J, Qi J, Montaner J, Wood E. Drug dealing cessation among a cohort of drug users in Vancouver, Canada. Drug Alcohol Depend. 2011 Nov 01; 118(2-3):459-63. PMID: 21664770; PMCID: PMC3182286.
    45. Werb D, Mills EJ, Debeck K, Kerr T, Montaner JS, Wood E. The effectiveness of anti-illicit-drug public-service announcements: a systematic review and meta-analysis. J Epidemiol Community Health. 2011 Oct; 65(10):834-40. PMID: 21558482.
      View in: PubMed
    46. Werb D, Rowell G, Guyatt G, Kerr T, Montaner J, Wood E. Effect of drug law enforcement on drug market violence: a systematic review. Int J Drug Policy. 2011 Mar; 22(2):87-94. PMID: 21392957.
      View in: PubMed
    47. Werb D, Wood E, Kerr T, Hershfield N, Palmer RW, Remis RS. Treatment costs of hepatitis C infection among injection drug users in Canada, 2006-2026. Int J Drug Policy. 2011 Jan; 22(1):70-6. PMID: 21051212.
      View in: PubMed
    48. Wood E, Werb D, Kazatchkine M, Kerr T, Hankins C, Gorna R, Nutt D, Des Jarlais D, Barré-Sinoussi F, Montaner J. Vienna Declaration: a call for evidence-based drug policies. Lancet. 2010 Jul 31; 376(9738):310-2. PMID: 20650517.
      View in: PubMed
    49. Werb D, Kerr T, Fast D, Qi J, Montaner JS, Wood E. Drug-related risks among street youth in two neighborhoods in a Canadian setting. Health Place. 2010 Sep; 16(5):1061-7. PMID: 20621542; PMCID: PMC2920044.
    50. Werb D, Mills EJ, Montaner JS, Wood E. Risk of resistance to highly active antiretroviral therapy among HIV-positive injecting drug users: a meta-analysis. Lancet Infect Dis. 2010 Jul; 10(7):464-9. PMID: 20610328.
      View in: PubMed
    51. Marshall BD, Werb D. Health outcomes associated with methamphetamine use among young people: a systematic review. Addiction. 2010 Jun; 105(6):991-1002. PMID: 20659059.
      View in: PubMed
    52. Werb D, Debeck K, Kerr T, Li K, Montaner J, Wood E. Modelling crack cocaine use trends over 10 years in a Canadian setting. Drug Alcohol Rev. 2010 May; 29(3):271-7. PMID: 20565519; PMCID: PMC4643832.
    53. Werb D, Fischer B, Wood E. Cannabis policy: time to move beyond the psychosis debate. Int J Drug Policy. 2010 Jul; 21(4):261-4. PMID: 20381329.
      View in: PubMed
    54. Werb D, Kerr T, Zhang R, Montaner JS, Wood E. Methamphetamine use and malnutrition among street-involved youth. Harm Reduct J. 2010 Mar 08; 7:5. PMID: 20210992; PMCID: PMC2841129.
    55. Werb D, Wood E. Commentary on Vorobjov et al., "Comparison of injection drug users who obtain syringes from pharmacies and syringe exchange programs in Tallinn, Estonia". Harm Reduct J. 2009 Nov 27; 6:33. PMID: 19943944; PMCID: PMC2789049.
    56. Werb D, Hayashi K, Fairbairn N, Kaplan K, Suwannawong P, Lai C, Kerr T. Drug use patterns among Thai illicit drug injectors amidst increased police presence. Subst Abuse Treat Prev Policy. 2009 Jul 21; 4:16. PMID: 19622171; PMCID: PMC2725037.
    57. Wood E, Werb D, Marshall BD, Montaner JS, Kerr T. The war on drugs: a devastating public-policy disaster. Lancet. 2009 Mar 21; 373(9668):989-90. PMID: 19282025.
      View in: PubMed
    58. Werb D, Kerr T, Montaner J, Wood E. The need for an evidence-based approach to controlling opium production in Afghanistan. J Public Health Policy. 2008 Dec; 29(4):440-8. PMID: 19079302.
      View in: PubMed
    59. Werb D, Kerr T, Marsh D, Li K, Montaner J, Wood E. Effect of methadone treatment on incarceration rates among injection drug users. Eur Addict Res. 2008; 14(3):143-9. PMID: 18552490.
      View in: PubMed
    60. Werb D, Kerr T, Small W, Li K, Montaner J, Wood E. HIV risks associated with incarceration among injection drug users: implications for prison-based public health strategies. J Public Health (Oxf). 2008 Jun; 30(2):126-32. PMID: 18387974.
      View in: PubMed
    61. Werb D, Kerr T, Li K, Montaner J, Wood E. Risks surrounding drug trade involvement among street-involved youth. Am J Drug Alcohol Abuse. 2008; 34(6):810-20. PMID: 19016187.
      View in: PubMed
    62. Werb D, Kerr T, Lai C, Montaner J, Wood E. Nonfatal overdose among a cohort of street-involved youth. J Adolesc Health. 2008 Mar; 42(3):303-6. PMID: 18295139; PMCID: PMC2290001.
    63. Werb D, Elliott R, Fischer B, Wood E, Montaner J, Kerr T. Drug treatment courts in Canada: an evidence-based review. HIV AIDS Policy Law Rev. 2007 Dec; 12(2-3):12-7. PMID: 18459192.
      View in: PubMed
    64. Werb D, Wood E, Small W, Strathdee S, Li K, Montaner J, Kerr T. Effects of police confiscation of illicit drugs and syringes among injection drug users in Vancouver. Int J Drug Policy. 2008 Aug; 19(4):332-8. PMID: 17900888; PMCID: PMC2529170.